News
Data delivery: Sanofi and GSK seek authorisation for COVID-19 vaccine
Sanofi and GlaxoSmithKline (GSK) have announced that they will submit data from both their booster and phase 3 effectiveness trials, thereby forming the basis for their COVID-19 vaccine regulatory applications.